BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24508492)

  • 1. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
    Funke-Kaiser A; Mann K; Colquhoun D; Zeller T; Hunt D; Simes J; Sullivan D; Sydow K; West M; White H; Blankenberg S; Tonkin AM;
    Int J Cardiol; 2014 Mar; 172(2):411-8. PubMed ID: 24508492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
    White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
    J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
    Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
    Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J;
    Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.
    Xue Y; Taub P; Iqbal N; Fard A; Clopton P; Maisel A
    Eur J Heart Fail; 2013 Dec; 15(12):1343-9. PubMed ID: 23887059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
    Shah KS; Marston NA; Mueller C; Neath SX; Christenson RH; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney J; Schreiber D; deFilippi C; Hogan CJ; Diercks DB; Limkakeng A; Anand IS; Wu AH; Clopton P; Jaffe AS; Peacock WF; Maisel AS
    Acad Emerg Med; 2015 May; 22(5):554-63. PubMed ID: 25908114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
    Wild PS; Schnabel RB; Lubos E; Zeller T; Sinning CR; Keller T; Tzikas S; Lackner KJ; Peetz D; Rupprecht HJ; Bickel C; Morgenthaler NG; Papassotiriou J; Tiret L; Münzel T; Blankenberg S
    Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.
    Holmager P; Schou M; Egstrup M; Gustafsson I; Goetze JP; Gustafsson F; Klausen TW; Faber J; Kistorp C
    J Card Fail; 2015 Mar; 21(3):250-7. PubMed ID: 25528198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
    J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
    Lassus J; Gayat E; Mueller C; Peacock WF; Spinar J; Harjola VP; van Kimmenade R; Pathak A; Mueller T; Disomma S; Metra M; Pascual-Figal D; Laribi S; Logeart D; Nouira S; Sato N; Potocki M; Parenica J; Collet C; Cohen-Solal A; Januzzi JL; Mebazaa A;
    Int J Cardiol; 2013 Oct; 168(3):2186-94. PubMed ID: 23538053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
    Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.